Goltz Daniel E, Hurley Eoghan T, Gustafson Jonathan, Sethi Paul, Koenig Karl, Garrigues Grant
Rothman Orthopaedic Institute, Orlando, Florida.
Department of Orthopaedic Surgery, Duke University Medical Center, Durham, North Carolina.
JB JS Open Access. 2025 Sep 17;10(3). doi: 10.2106/JBJS.OA.25.00114. eCollection 2025 Jul-Sep.
» Opioid-related dependence remains a major concern following surgery in the United States, driving increased interest in non-opioid, multimodal pain control strategies within orthopaedic surgery. » Liposomal bupivacaine is an extended-release anesthetic approved for specific nerve blocks and offers the potential to prolong analgesia without the need for post-operative catheters. » Liposomal bupivacaine is currently approved for use in interscalene brachial plexus blocks, sciatic nerve blocks in the popliteal fossa, and adductor canal blocks. » Despite mixed clinical trial results compared to unencapsulated bupivacaine, liposomal formulations may provide clinical and economic advantages in selected orthopaedic settings.
在美国,术后阿片类药物相关的成瘾问题仍然是一个主要担忧,这使得骨科手术中对非阿片类多模式疼痛控制策略的兴趣日益增加。脂质体布比卡因是一种获批用于特定神经阻滞的缓释麻醉剂,具有无需术后留置导管即可延长镇痛时间的潜力。脂质体布比卡因目前已获批用于肌间沟臂丛神经阻滞、腘窝坐骨神经阻滞和收肌管阻滞。尽管与未包封的布比卡因相比,临床试验结果不一,但脂质体制剂在某些骨科手术中可能具有临床和经济优势。